Literature DB >> 23747036

The role of T cell immunity in HIV-1 infection.

C Mee Ling Munier1, Anthony D Kelleher, Stephen J Kent, Robert De Rose.   

Abstract

The interplay between the T cell immune response and human immunodeficiency virus (HIV)-1 largely determines the outcome of infection. Typically, the virus overcomes the immune defences leading to a gradual decline in function that permits the development of disease. In recent years, a concerted effort in comparing T cell responses between 'controllers' and 'progressors' is beginning to identify the T cell subsets and factors that affect disease progression related to the effector functions of both CD4 and CD8 T cells. These efforts are providing opportunities for development of novel therapies and vaccines.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23747036     DOI: 10.1016/j.coviro.2013.05.009

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  6 in total

1.  HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.

Authors:  Weihua Li; Chuanyun Li; Wei Xia; Xiuhui Li
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.

Authors:  Yi Yang; Weilai Sun; Jingjing Guo; Guangyu Zhao; Shihui Sun; Hong Yu; Yan Guo; Jungfeng Li; Xia Jin; Lanying Du; Shibo Jiang; Zhihua Kou; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

4.  Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing.

Authors:  Zhixiong Zhong; Heming Wu; Qifeng Zhang; Wei Zhong; Pingsen Zhao
Journal:  J Transl Med       Date:  2019-01-11       Impact factor: 5.531

5.  Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.

Authors:  Ying Pan; Zi-Ning Zhang; Lin-Bo Yin; Ya-Jing Fu; Yong-Jun Jiang; Hong Shang
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

6.  Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.

Authors:  Edouard Lhomme; Laura Richert; Zoe Moodie; Chloé Pasin; Spyros A Kalams; Cecilia Morgan; Steve Self; Stephen C De Rosa; Rodolphe Thiébaut
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.